Target intelligence / Profile preview

Invertebrate gamma-aminobutyric acid-gated chloride receptor (iGABACl)

Target
iGABACl
Molecular classification
Ion channel, Cys-loop ligand-gated ion channel, Receptor
01

Overview

Invertebrate gamma-aminobutyric acid (GABA)-gated chloride receptors are pentameric ligand-gated ion channels that mediate fast inhibitory neurotransmission in the nervous systems of insects, arachnids, and nematodes [1, 2]. These receptors are members of the Cys-loop superfamily and function by opening a chloride-selective pore upon binding the neurotransmitter GABA, leading to membrane hyperpolarization and the suppression of neuronal activity [1, 3]. They are critical for regulating motor coordination, sensory processing, and behavior in invertebrates [2]. Due to their essential role and structural differences from vertebrate GABA-A receptors, they serve as primary targets for numerous insecticides and parasiticides, including phenylpyrazoles (e.g., fipronil), cyclodienes (e.g., dieldrin), and isoxazolines (e.g., fluralaner) [2, 4]. These compounds typically act as non-competitive antagonists that bind within the channel pore to block ion flow, leading to overexcitation of the nervous system and death of the organism [4, 5]. However, the development of resistance, often mediated by mutations in the Rdl (resistance to dieldrin) gene, and potential cross-reactivity with mammalian GABA receptors present significant therapeutic and environmental challenges [1, 5].

Other names
Invertebrate GABA receptorRDL receptoriGABAClGABA-gated chloride channelIonotropic GABA receptor
02

Mechanism of action

Non-competitive antagonism of the chloride channel pore, which blocks the inhibitory effect of GABA and leads to lethal neuronal overstimulation [2, 4, 5].

03

Biological functions

Inhibitory neurotransmissionChloride ion transportRegulation of neuronal excitabilityMotor coordination
04

Disease associations

Ectoparasitic infestationEndoparasitic infectionAgricultural pest infestation
05

Safety considerations

Mammalian neurotoxicity (e.g., seizures, tremors)Environmental toxicity to non-target species (e.g., honeybees)Development of target-site resistance
06

Interacting drugs

Fipronil

11 more in the full profile.

07

Biomarkers

Rdl A301S mutationRdl A301G mutationT350M mutation

Beyond the preview

Go deeper on Invertebrate gamma-aminobutyric acid-gated chloride receptor (iGABACl).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invertebrate gamma-aminobutyric acid-gated chloride receptor (iGABACl).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call